MedTech MeetUp: University of Rochester
Add to calendar
Thursday, August 16, 2018
12:00 pm – 5:00 pm
Location: University of Rochester | Saunders Research Building | 265 Crittenden Boulevard Rochester, NY 14620
Agenda
12:00-12:30: Member arrival and registration
Session 1
- Peter Robinson, Vice President & COO of University of Rochester Medical Center. EDI is an independent, nonprofit entity that will identify promising drug candidates and move them toward clinical trials.
-
The University of Rochester, University at Buffalo, and Roswell Park Comprehensive Cancer Center have joined together to form a powerful new drug discovery partnership that aims to convert the institutions’ scientific breakthroughs into viable pharmaceuticals for commercialization and strengthen the region as a hub for life sciences research and development. EDI will be supported by more than $47 million during its first five years: $35.4 million from the New York State Life Science Initiative and $12 million in in-kind contributions from the three partner institutions. Over the next five years, it is anticipated that EDI will generate several new multimillion-dollar life science companies, new life science patents, and new jobs resulting from the life science companies created out of EDI.
- Leslie Kimerling, CEO of Double Helix Optics. Double Helix Optics is the recent winner of the $1 million prize from the Luminate Accelerator competition.
-
Double Helix Optics was the winner of the first round of the Luminate NY competition. The Boulder, Colorado-based company received top honors at Luminate NY’s inaugural “Light Tomorrow with Today” Demo Day competition, held in the main tent at the Xerox International Jazz Festival in Downtown Rochester. The company will receive $1 million in follow-on funding from New York State through the Finger Lakes Forward Upstate Revitalization. Initiative. As required by the award, Double Helix will commit to establishing operations in Rochester for at least the next 18 months. Double Helix Optics garnered the grand prize for its Light Engineering (TM) technology. As 3D information is increasingly incorporated into real-world applications, a major challenge has been integrating depth information with increased resolution. The company’s technology overcomes these limitations, providing improvement in depth resolution where current technologies fail. Its SPINDLE (R). Their 3D nano-imaging module seamlessly integrates with existing microscopes, cameras, and other optical instruments to turn 2D imaging into 3D information capture.
- Stephen Dewhurst, Associate VP for Health Sciences Research
- Luísa Davies, Principal Scientist, Manager of Upstate Stem Cell cGMP Facility
Session 2
- Greg Gdowski, PhD., Executive Director of CMTI, Center for Medical Technology & Innovation
-
The University of Rochester’s Center for Medical Technology & Innovation (CMTI) resides in the Biomedical Engineering Department; and provides a collaborative environment between the Medical Center and adjacent campus to unite the talents and resources of the Edmund A. Hajim School of Engineering & Applied Sciences and the School of Medicine & Dentistry with industry partners to improve clinical care. The CMTI is integrated into Rochester’s evolving entrepreneurial ecosystem, which supports the translation of multidisciplinary applied research to product development to improve patient care. With our corporate partners, students and faculty we will offer innovative device solutions that address real problems. The CMTI provides clinicians, residents, fellows, and staff who previously didn’t have the time, resources, or capability, with the ability to work side-by-side with engineers and entrepreneurs to pursue their ideas. This is accomplished through a one-year Medical Technology & Innovation Masters Degree Program in Biomedical Engineering focused on medical device product development and commercialization. This program trains and prepares individuals for the diverse needs of the healthcare industry with the objective of providing professionals to the medical device industry.
- David Mitten, M.D., Executive Director of Healthlabs
-
At the University of Rochester, the UR Health Lab is transforming the way data science is being used in medicine by developing novel tools that capture new data streams, analyze previously unseen patterns and enable health care providers to provide individualized treatments that are more responsive, effective and precise. Within the UR Health Lab, clinicians and researchers work alongside data scientists, computer scientists and electrical and computer engineers. They devise breakthrough systems that incorporate the most advanced machine learning models, virtual and augmented realities, 3D imaging modalities and wearable multifunction sensors.
- Brenda Bartock, Telehealth Clinical Project Director
-
The University of Rochester Telehealth Consortium has been in operation since October 2011 to improve access to health care and education provided by University experts by collectively leveraging telecommunication technology. The Consortium highlights our local wealth of knowledge in designing and implementing functional telehealth based care systems in the Rochester region and beyond. Our members include a diverse mix of University departments, local health IT vendors, and representatives from local insurers and other community based provider groups, such as Excellus, Rochester General’s Office of Telehealth and Finger Lakes Community Health. We are developing our resource center with web presence to link those interested and conversant in telehealth with those looking to support, study, or develop health care delivery models that use mobile and internet-based technologies to achieve efficient, cost-effective, and high quality patient-centered care.
- Paul Ballentine, CEIS, University of Rochester CAT - corporate collaborative funding opportunities
-
Our mission is to promote economic development in New York State by bringing together companies and university researchers who have areas of common interest and encouraging collaboration through funding and outreach. Over the past ten years, CEIS funding has been leveraged to generate over $702 million in economic impact and the creation of 239 new jobs. By bringing together multiple universities, companies, government agencies, and economic development organizations in a collaborative environment, we provide leadership in the identification and realization of technology-driven economic development in the Finger Lakes region.
4:00-5:00: Networking Reception